Contineum Therapeutics (CTNM) Return on Equity: 2024
Historic Return on Equity for Contineum Therapeutics (CTNM) over the last 1 years, with Dec 2024 value amounting to -0.21%.
- Contineum Therapeutics' Return on Equity was N/A to -0.21% in Q4 2024 from the same period last year, while for Dec 2024 it was -0.21%, marking a year-over-year change of. This contributed to the annual value of -0.65% for FY2024, which is N/A change from last year.
- Latest data reveals that Contineum Therapeutics reported Return on Equity of -0.21% as of Q4 2024, which was down 24.84% from -0.17% recorded in Q3 2024.
- Contineum Therapeutics' Return on Equity's 5-year high stood at -0.17% during Q3 2024, with a 5-year trough of -0.44% in Q2 2024.
- Moreover, its 1-year median value for Return on Equity was -0.24% (2024), whereas its average is -0.27%.